Clinical Trial Details

Trial ID: L0568
Source ID: IRCT201610069014N121
Associated Drug: L-Carnitin
Title: Effect of treatment with L-Carnitin versus no treatment on the stage of disease in patients with nonalcoholic fatty liver: a single blind randomized clinical trial
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: nonalcoholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: Routine treatment plus oral L-Carnitin 1 gr per day for 6 months. Intervention 2: Just routine treatment.;Treatment - Drugs;Routine treatment plus oral L-Carnitin 1 gr per day for 6 months;Just routine treatment
Outcome Measures: Assessing the stage of disease. Timepoint: before and 6 months after treatment. Method of measurement: using liver sonography.Assessing liver enzymes. Timepoint: before and 6 months after treatment. Method of measurement: using laboratory tests.
Sponsor/Collaborators: Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Gender: All
Age: no limitno limit
Phases: Phase 2
Enrollment: 120
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment, Other design features: Randomization: The patients will be randomly assigned to intervention and control groups using block randomization.<br>B
Start Date: 08/10/2016
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/9559